These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 26235208)
41. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases? Schmid-Tannwald C; Thomas S; Ivancevic MK; Dahi F; Rist C; Sethi I; Oto A Acta Radiol; 2014 Jun; 55(5):515-23. PubMed ID: 23986455 [TBL] [Abstract][Full Text] [Related]
42. Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis. Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Grussu F; Fernandez JJS; Simo AC; Sarro NV; Fernandez-Coello A; Bruna J; Cos M; Perez-Lopez R; Majos C Eur Radiol; 2022 Jun; 32(6):3705-3715. PubMed ID: 35103827 [TBL] [Abstract][Full Text] [Related]
43. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms. Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148 [TBL] [Abstract][Full Text] [Related]
44. DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma. Shin KE; Ahn KJ; Choi HS; Jung SL; Kim BS; Jeon SS; Hong YG Clin Radiol; 2014 Jun; 69(6):e264-72. PubMed ID: 24594379 [TBL] [Abstract][Full Text] [Related]
45. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts. Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573 [TBL] [Abstract][Full Text] [Related]
46. Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study. Ortiz-Ramón R; Larroza A; Ruiz-España S; Arana E; Moratal D Eur Radiol; 2018 Nov; 28(11):4514-4523. PubMed ID: 29761357 [TBL] [Abstract][Full Text] [Related]
47. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions. Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas. Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229 [TBL] [Abstract][Full Text] [Related]
49. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504 [TBL] [Abstract][Full Text] [Related]
50. Spatiotemporal habitats from multiparametric physiologic MRI distinguish tumor progression from treatment-related change in post-treatment glioblastoma. Kim M; Park JE; Kim HS; Kim N; Park SY; Kim YH; Kim JH Eur Radiol; 2021 Aug; 31(8):6374-6383. PubMed ID: 33569615 [TBL] [Abstract][Full Text] [Related]
51. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI. Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892 [TBL] [Abstract][Full Text] [Related]
52. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation. Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493 [TBL] [Abstract][Full Text] [Related]
53. Differences In High-Intensity Signal Volume Between Arterial Spin Labeling And Contrast-Enhanced T1-Weighted Imaging May Be Useful For Differentiating Glioblastoma From Brain Metastasis. Ganbold M; Harada M; Khashbat D; Abe T; Kageji T; Nagahiro S J Med Invest; 2017; 64(1.2):58-63. PubMed ID: 28373629 [TBL] [Abstract][Full Text] [Related]
54. Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence. Blasel S; Zagorcic A; Jurcoane A; Bähr O; Wagner M; Harter PN; Hattingen E J Neuroimaging; 2016; 26(1):116-23. PubMed ID: 25907688 [TBL] [Abstract][Full Text] [Related]
55. Spatially regularized estimation of the tissue homogeneity model parameters in DCE-MRI using proximal minimization. Bartoš M; Rajmic P; Šorel M; Mangová M; Keunen O; Jiřík R Magn Reson Med; 2019 Dec; 82(6):2257-2272. PubMed ID: 31317577 [TBL] [Abstract][Full Text] [Related]
56. Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma. Linnik IV; Scott ML; Holliday KF; Woodhouse N; Waterton JC; O'Connor JP; Barjat H; Liess C; Ulloa J; Young H; Dive C; Hodgkinson CL; Ward T; Roberts D; Mills SJ; Thompson G; Buonaccorsi GA; Cheung S; Jackson A; Naish JH; Parker GJ Magn Reson Med; 2014 May; 71(5):1854-62. PubMed ID: 23798369 [TBL] [Abstract][Full Text] [Related]
57. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678 [TBL] [Abstract][Full Text] [Related]
58. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. Roberts C; Issa B; Stone A; Jackson A; Waterton JC; Parker GJ J Magn Reson Imaging; 2006 Apr; 23(4):554-63. PubMed ID: 16506143 [TBL] [Abstract][Full Text] [Related]
59. Using intraoperative dynamic contrast-enhanced T1-weighted MRI to identify residual tumor in glioblastoma surgery. Özduman K; Yıldız E; Dinçer A; Sav A; Pamir MN J Neurosurg; 2014 Jan; 120(1):60-6. PubMed ID: 24138206 [TBL] [Abstract][Full Text] [Related]
60. Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics. Priya S; Liu Y; Ward C; Le NH; Soni N; Pillenahalli Maheshwarappa R; Monga V; Zhang H; Sonka M; Bathla G Sci Rep; 2021 May; 11(1):10478. PubMed ID: 34006893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]